Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Chenwei WangYadi LiaoJiliang QiuYichuan YuanYuanping ZhangKai LiRuhai ZouYongjin WangDinglan ZuoWei HeYun ZhengBin-Kui LiYichuan YuanPublished in: Journal of cancer research and clinical oncology (2020)
TACE combined with ablation is safe and superior to TACE alone in tumour control and prolonging overall survival in recurrent intermediate-stage HCC after hepatectomy.
Keyphrases